Workflow
Vivos Therapeutics Completes Acquisition of The Sleep Center of Nevada
Globenewswire· 2025-06-11 12:30
Over $11 million in new financing secured by Vivos, including a senior secured loan from Streeterville Capital and an equity private placement by existing investor New Seneca Partners LITTLETON, Colo., June 11, 2025 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. ("Vivos" or the "Company") (NASDAQ: VVOS), a leader in delivering and promoting sleep wellness and health through its proprietary, non-invasive treatments for obstructive sleep apnea (OSA), today announced the closing of its acquisition of the operati ...
Robinhood Markets, Inc. Reports May 2025 Operating Data
Globenewswire· 2025-06-11 12:30
MENLO PARK, Calif., June 11, 2025 (GLOBE NEWSWIRE) -- Robinhood Markets, Inc. ("Robinhood") (NASDAQ: HOOD) today reported select monthly operating data for May 2025. Total Securities Lending Revenue ($M) $33 $25 +32% $23 +43% About Robinhood Robinhood Markets, Inc. (NASDAQ: HOOD) transformed financial services by introducing commission-free stock trading and democratizing access to the markets for millions of investors. Today, Robinhood lets you trade stocks, options, futures (which includes options on futu ...
AREVA Institute and SeaStar Medical Announce DoD Award of Prestigious Military Grant to AREVA Institute to Evaluate SeaStar Medical’s SCD Therapy to Advance Breakthrough Burn and Sepsis Research
Globenewswire· 2025-06-11 12:25
$2 million in DoD funding enables the evaluation of SeaStar Medical’s SCD therapy in the setting of severe burns, inhalation injury, and sepsisSAN ANTONIO, Texas and DENVER, Colorado, June 11, 2025 (GLOBE NEWSWIRE) -- The Autonomous Reanimation and Evacuation (AREVA) Research Institute and SeaStar Medical (Nasdaq: ICU) announced today that a new United States Department of Defense (DoD) grant has been awarded to AREVA. The grant is one of four selected out of 160 total submissions by the 2024 Military Burn ...
Apollo Capital Releases Investor Presentation Highlighting Plan to Make MediPharm Labs the World’s Leading International Medical Cannabis Company
Globenewswire· 2025-06-11 12:25
TORONTO, June 11, 2025 (GLOBE NEWSWIRE) -- Apollo Technology Capital Corporation (“Apollo Capital”), which together with its affiliates and associates collectively is one of the largest shareholders of MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm”, “MediPharm Labs”, or the “Company”), owning approximately 3% of the Company’s common stock, today issued a presentation to set forth their ambitious plan to grow your investment and help turn MediPharm around. Outlines Commitment to I ...
ASP Isotopes Inc. Enhances the Quantum Leap Energy LLC (QLE) Executive Leadership Team with the Appointment of Ryno Pretorius as Chief Executive Officer of QLE
Globenewswire· 2025-06-11 12:23
WASHINGTON , June 11, 2025 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes” or the “Company”), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries, today announced the appointment of Dr. Ryno Pretorius, PhD as Chief Executive Officer of Quantum Leap Energy LLC (QLE), the Company’s subsidiary that is pursuing an initiative to develop and commercialize advanced nuclear fuels, such as High Assay L ...
NFI Subsidiary Alexander Dennis announces consultation on UK manufacturing strategy
Globenewswire· 2025-06-11 12:20
LARBERT, United Kingdom, June 11, 2025 (GLOBE NEWSWIRE) -- (TSX: NFI, OTC: NFYEF, TSX: NFI.DB) NFI Group Inc. (NFI) a leader in propulsion-agnostic bus and coach mobility solutions, announced today that its subsidiary, Alexander Dennis Limited (Alexander Dennis), is entering into a consultation on a new strategy for its United Kingdom (UK) manufacturing operations. The refocused strategy results from the completion of a detailed business review and is intended to adjust the UK business to changing market dy ...
Telos Corporation Secures Multi-Million Dollar Contract Renewal with U.S. Air Force
Globenewswire· 2025-06-11 12:15
U.S. Air Force looks to Xacta for critical automation and training solutionsASHBURN, Va., June 11, 2025 (GLOBE NEWSWIRE) -- Telos Corporation (NASDAQ: TLS), a leading provider of cyber, cloud and enterprise security solutions for the world’s most security-conscious organizations, today announced a contract extension with the U.S. Air Force to help meet complex compliance requirements with Telos’ flagship cyber governance, risk and compliance (GRC) platform, Xacta®. The Company secured a $3.7 million option ...
Brera Holdings PLC (Nasdaq: BREA) and Toronto Blizzard Grassroots Soccer Partnership Targets Youth Sports, an Estimated $69 Billion Industry by 2030
Globenewswire· 2025-06-11 12:15
Worth $37.5B in 2022, Youth Sports are Projected to Hit $69.4B by 2030 According to Profluence.com, with Sports Tourism’s Total Economic Impact $91.8B in 2021 Joe Parolini is the Owner and Coach of Toronto Blizzard Joe Parolini is the Owner and Coach of Toronto Blizzard Joe Parolini is the Owner and Coach of Toronto Blizzard Dublin, Ireland; Naples, Italy; and Toronto, Canada, June 11, 2025 (GLOBE NEWSWIRE) -- Brera Holdings PLC (“Brera Holdings” or the “Company”) (Nasdaq: BREA), an Ireland-based intern ...
Cellectar Biosciences Provides Update on CLOVER-2 Phase 1 Clinical Trial of Iopofosine I 131 in Pediatric Patients with Relapsed/Refractory High-Grade Glioma
Globenewswire· 2025-06-11 12:05
In Patients Receiving a Minimum of 55 mCi an Average 5.4 Months of PFS was Observed: Twice the Reported 2.25 MedianFLORHAM PARK, N.J., June 11, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment of cancer, today announced initial results as of June 10, 2025, from the CLOVER-2 Phase 1 clinical trial evaluating iopofosine I 131 in relapsed/refractory pediatric high-grade glioma ...
Vera Bradley Announces First Quarter Fiscal Year 2026 Results
Globenewswire· 2025-06-11 12:01
First quarter consolidated net revenues totaled $51.7 million Financial condition remains strong with $86 million in liquidity and no debt FORT WAYNE, Ind., June 11, 2025 (GLOBE NEWSWIRE) -- Vera Bradley, Inc. (Nasdaq: VRA) (the “Company”) today announced its financial results for the first quarter of the fiscal year ending January 31, 2026 (“Fiscal 2026”). First Quarter Comments Jackie Ardrey, Chief Executive Officer commented, “Our first quarter results were disappointing as top line and profitability tre ...